No Data
Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Biohaven Ltd. (BHVN) and Arrowhead Pharmaceuticals (ARWR)
Arrowhead Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley
Arrowhead Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley
Selling Arrowhead Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders
Even though Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has fallen by 12% over the past week , insiders who sold US$3.1m worth of stock over the past year have had less luck. Insiders would probabl
Express News | HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $90 Price Target
Express News | Arrowhead Phrmctcls Inc : Morgan Stanley Cuts Target Price to $27.00 From $36.00
Cantor Picks 14 Undervalued Biotech Stocks Worth a Second Look